Quest Diagnostics Raises 2026 Earnings Guidance
Rising testing volumes allow laboratories to offset per-test revenue declines and future regulatory costs.
Updated on Oct. 22, 2026 in Healthcare
Live Poll
Do you still trust large healthcare companies after they report a data security breach?
Quest Diagnostics reported third-quarter 2026 revenue of $3.097 billion, a 10% year-over-year increase driven by higher testing volumes. The laboratory services provider also confirmed a data breach in its Quanum LSM system, noting that operations remain unaffected.
Why it matters
Rising clinical demand from an aging population is fueling growth, though the industry faces looming regulatory pressures under the Protecting Access to Medicare Act (PAMA). Operators must balance operational productivity through automation with the increasing costs of securing sensitive patient data.
Third-quarter revenue reached $3.097 billion, up 10% year-over-year, while adjusted operating income climbed 13% to $517 million. Despite a 14.5% jump in requisition volume, revenue per requisition fell 4.2% compared to the prior year.
The players
Quest Diagnostics
A national clinical laboratory company that manages diagnostic testing and patient data systems at scale.
The details
Growth stems from a strategic focus on clinical care for an aging population, supported by AI-driven productivity gains. While the firm raised its full-year 2026 earnings guidance, it continues to navigate the financial impact of the Protecting Access to Medicare Act, which is expected to reduce total revenues by approximately 1% in 2027.
Timeline
2014: Enactment of the Protecting Access to Medicare Act.
Q3 2026: Financial results period for the reported quarter.
October 22, 2026: Date of the financial report publication.
2027: Year of the projected 1% revenue impact from PAMA regulations.
2027-2029: Period for an expected cumulative PAMA revenue impact of less than 1.3%.
Market Landscape
The firm is managing its long-term financial trajectory in accordance with the 2014 Protecting Access to Medicare Act. This update follows a pattern of adjusting service volume and operational efficiency to mitigate the act's cumulative impact on laboratory reimbursements.
Operators should monitor upcoming reimbursement updates for 2027 as PAMA-related adjustments begin to take hold. Additionally, the recent Quanum LSM breach serves as a signal to prioritize audit logs and access controls for all internal clinical management systems.
The takeaway
Healthcare providers should utilize this period of growth to invest in automated workflows that offset downward pressure on per-requisition revenue. Management should also review cybersecurity incident response protocols to ensure systems can withstand unauthorized access attempts without interrupting patient care.
Further reading
For broader insights into current sector shifts, visit Healthcare.
Live Poll
Do you still trust large healthcare companies after they report a data security breach?
